Patent ID: 11897945
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. The method of claim 1, wherein treatment with the pharmaceutical composition:
reduces a subject's Total Nasal Symptom Score (TNSS);
reduces a subject's Total Ocular Symptom Score (TOSS);
reduces a subject's Total Symptom Score (TSS);
reduces a subject's Daily Medication Score (DMS);
reduces a subject's Combined Symptom and Medication Score (CSMS);
reduces a subject's birch skin prick test (SPT) mean wheal diameter; and/or
increases a subject's number of well days in which rescue medication is not utilized and the subject's TSS is ≤2 of 18.